KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

A research team at Western Michigan University Homer Stryker M.D. School of Medicine has made a significant discovery.

KALAMAZOO, MI -- Scientists at Western Michigan University Homer Stryker School of Medicine (WMed) have made a ...

A team of researchers at Western Michigan University's Homer Stryker M.D. School of Medicine has made a monumental ...

Could CKD in these patients stem from latent, undiagnosed genetic conditions ... "These included polycystic kidney disease, ...

The case was a tricky one, a surgery was inevitable. The patient had lost a lot of blood. He was also in severe pain. Then, ...

In an indication that has proved difficult for biopharma to conquer, Regulus Therapeutics Inc. disclosed further positive data from its ongoing phase Ib study testing RGLS-8429 in autosomal dominant ...

Autosomal dominant ... chromosome to potentially "cancel out" the negative effects of X-linked mutations, they are far more likely than women to be affected by X chromosome-linked recessive diseases.

The complex nephrectomy was followed by a kidney transplant. The patient was discharged three days after the surgery and is ...

Shortly after failing a Parkinson's disease study, Sanofi's venglustat has missed the mark in another trial in autosomal dominant ... inherited kidney disease. The genetic disorder causes cysts ...

Autosomal dominant polycystic kidney disease (ADPKD) is the most common, potentially lethal genetic disorder characterized by the ... microenvironment of ADPKD and the potential therapeutic effects of ...